REVIEWS  LATEST DEVELOPMENTS IN SFA MANAGEMENT 

The Journal of Cardiovascular Surgery 2014 August;55(4):461-4

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Prime time for drug eluting balloons in SFA interventions?

Brodmann M. ✉

Division of Angiology, Medical University of Graz, Graz, Austria

Peripheral arterial disease most commonly affects the femoropopliteal segment. Despite enormous improvements in device and treatment technology the long-term patency rate and clinical benefit of endovascular treatment in the respective vascular bed is not satisfying. Drug coated balloon technology as a treatment option in femoropopliteal disease has shown encouraging results in first-in-man trials, which have now been proven in large randomized controlled trials.